About VAHO
Founded in 1990, the Virginia Association of Hematologists and Oncologists (VAHO) is the largest oncology professional organization in the state. VAHO comprises a powerful community of oncologists, nurse practitioners, physician assistants, pharmacists, and other multidisciplinary care providers involved in the treatment of patients with cancer.
Events Calendar view all
Minimal Resident Disease (MRD) as an Endpoint in the Context of Multiple MyelomaThu | 2026 Spring MeetingThu |
Industry News view all
03/23/2026Bristol Myers Squibb Announces Positive Phase 3 Results from the SUCCESSOR-2 Study of Oral Mezigdomide in Relapsed or Refractory Multiple MyelomaBristol Myers Squibb announced positive Phase 3 results from the SUCCESSOR-2 trial, showing that the oral combination of mezigdomide with carfilzomib and dexamethasone significantly improved progression-free survival compared to standard therapy in patients with relapsed or refractory multiple myeloma. The regimen demonstrated a consistent safety profile and represents the first successful Phase 3 study for mezigdomide, highlighting its potential as a new oral treatment option for patients with limited alternatives. |
03/19/2026BMS & Microsoft Collaborate on AI-Driven Early Detection of Lung Cancer InitiativeBristol Myers Squibb and Microsoft announced a collaboration to advance AI-driven early detection of lung cancer by integrating FDA-cleared radiology algorithms into Microsoft’s imaging platforms. The initiative aims to help clinicians identify lung nodules and diagnose cancer earlier, improve workflow efficiency, and expand access to early detection—particularly in underserved and rural communities. By combining oncology expertise with scalable AI infrastructure, the partnership seeks to improve diagnostic accuracy, accelerate follow-up care, and ultimately enhance patient outcomes while addressing disparities in lung cancer detection. |
03/19/2026Update: SB536Senate Bill 536 (SB 536), initially expanded into a sweeping medical malpractice overhaul that would have significantly increased liability exposure, was scaled back following strong advocacy from physician organizations and stakeholders. The final conference report removed provisions to raise the malpractice cap, expand the statute of limitations, and add prejudgment interest, instead focusing on data collection from insurers to inform future policy decisions. This outcome preserves the current legal framework while setting the stage for more evidence-based malpractice reform discussions in Virginia. |
